Cargando…

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

Background: Biomarkers for predicting response to immune checkpoint inhibitors (ICI) are scarce and often lack external validation. This study provides a comprehensive investigation of pretreatment C-reactive protein (CRP) levels as well as its longitudinal trajectories as a marker of treatment resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riedl, Jakob M., Barth, Dominik A., Brueckl, Wolfgang M., Zeitler, Gloria, Foris, Vasile, Mollnar, Stefanie, Stotz, Michael, Rossmann, Christopher H., Terbuch, Angelika, Balic, Marija, Niedrist, Tobias, Bertsch, Thomas, Stoeger, Herbert, Pichler, Martin, Olschewski, Horst, Absenger, Gudrun, Ficker, Joachim H., Gerger, Armin, Posch, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464328/ https://www.ncbi.nlm.nih.gov/pubmed/32824580 http://dx.doi.org/10.3390/cancers12082319

Ejemplares similares

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
por: Klöckl, Marie-Christin, et al.
Publicado: (2020)

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
por: Moik, Florian, et al.
Publicado: (2019)

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
por: Mollnar, S., et al.
Publicado: (2020)

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
por: Brueckl, Wolfgang M., et al.
Publicado: (2020)

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
por: Stelzl, Adrian, et al.
Publicado: (2020)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
por: Barth, Dominik A., et al.
Publicado: (2022)

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Long-term cardiovascular complications in stage I seminoma patients
por: Terbuch, A., et al.
Publicado: (2017)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment
por: Dandachi, Nadia, et al.
Publicado: (2020)

Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
por: Stotz, Michael, et al.
Publicado: (2016)

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
por: Szkandera, J, et al.
Publicado: (2013)

Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
por: Müller, Moritz, et al.
Publicado: (2021)

Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)
por: Brueckl, Natalie F., et al.
Publicado: (2021)

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
por: Szkandera, Joanna, et al.
Publicado: (2013)

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
por: Barth, Dominik A., et al.
Publicado: (2022)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
por: Brcic, Luka, et al.
Publicado: (2018)

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study
por: Posch, Florian, et al.
Publicado: (2017)

Reflex testing in non-small cell lung carcinoma using DNA- and RNA-based next-generation sequencing—a single-center experience
por: Zacharias, Martin, et al.
Publicado: (2021)

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
por: Posch, Florian, et al.
Publicado: (2022)

Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
por: Illini, Oliver, et al.
Publicado: (2022)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
por: Barth, Dominik Andreas, et al.
Publicado: (2020)

Immune Aging and Immunotherapy in Cancer
por: Kaiser, Melanie, et al.
Publicado: (2021)

ASCO update: lung cancer
por: Absenger, Gudrun, et al.
Publicado: (2017)

MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms
por: Posch, Florian, et al.
Publicado: (2021)

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience
por: Scheipl, Susanne, et al.
Publicado: (2021)

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients
por: Lembeck, Anna L., et al.
Publicado: (2020)

The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer
por: Stotz, Michael, et al.
Publicado: (2020)

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
por: Klocker, Eva Valentina, et al.
Publicado: (2020)

Imatinib for right heart failure in COPD
por: Douschan, Philipp, et al.
Publicado: (2018)

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
por: Szkandera, J, et al.
Publicado: (2014)

Endotyping COPD: hypoxia-inducible factor-2 as a molecular “switch” between the vascular and airway phenotypes?
por: Myronenko, Oleh, et al.
Publicado: (2023)

Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
por: Brueckl, Wolfgang M., et al.
Publicado: (2018)

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients
por: Benezeder, Theresa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1bpntolft2daru3kch97painr8